Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-03-26 @ 3:21 PM
NCT ID:
NCT02690727
Eligibility Criteria:
Inclusion Criteria:
* Healthy male volunteers; aged 18 to 45 years;
* Body mass index (BMI) between 18.0 and 30.0 kg/m2 inclusive, weight ≥ 50 kg;
* Non- smokers or ex-smokers;
* Able to give informed consent.
Exclusion Criteria:
* Subjects with evidence or history of clinically significant disease;
* Positive results to HIV Ag/Ab Combo, Hepatitis B surface Antigen (HBsAG (B) (hepatitis B)) or Hepatitis C Virus (HCV (C)) tests;
* Subjects who have received any investigational drug in the previous 28 days;
* Subjects participated in a study with PI3k inhibitors at least once in past year;
* Subjects who have received drugs metabolised by CYP3A4 enzyme in the previous 28 days.
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT02690727
Study Brief:
Protocol Section:
NCT02690727